Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)
CUSIP: 00847X104
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock, Par Value $0.001 per share
- Shares outstanding
- 59,431,072
- Total 13F shares
- 69,390,256
- Share change
- +478,875
- Total reported value
- $2,461,883,479
- Put/Call ratio
- 64%
- Price per share
- $35.48
- Number of holders
- 188
- Value change
- +$6,215,421
- Number of buys
- 85
- Number of sells
- 99
Report period
Q1 2020
Institutions
188
Top holders
10
AGIO full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00847X104
Recent filing periods:
Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
8,828,462
|
$421,559,000 | — | 31 Dec 2019 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
13%
|
7,961,723
|
$380,172,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.4%
|
5,606,855
|
$267,727,000 | — | 31 Dec 2019 | |
| Capital International Investors |
13F
|
Company |
7.6%
|
4,532,814
|
$216,442,000 | — | 31 Dec 2019 | |
| Bellevue Group AG |
13F
|
Company |
6.6%
|
3,924,954
|
$187,417,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.6%
|
3,893,394
|
$185,908,000 | — | 31 Dec 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.7%
|
2,821,635
|
$134,733,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
3.9%
|
2,293,526
|
$109,516,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
1,884,786
|
$89,999,000 | — | 31 Dec 2019 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
2.6%
|
1,533,749
|
$73,237,000 | — | 31 Dec 2019 | |
| Invesco Ltd. |
13F
|
Company |
2.4%
|
1,403,072
|
$66,997,000 | — | 31 Dec 2019 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.1%
|
1,250,000
|
$59,688,000 | — | 31 Dec 2019 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.9%
|
1,108,401
|
$52,926,000 | — | 31 Dec 2019 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.8%
|
1,087,883
|
$51,696,000 | — | 31 Dec 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.8%
|
1,086,844
|
$51,898,000 | — | 31 Dec 2019 | |
| Erste Asset Management GmbH |
13F
|
Company |
1.8%
|
1,078,700
|
$51,801,376 | — | 31 Dec 2019 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.8%
|
1,044,127
|
$49,857,000 | — | 31 Dec 2019 | |
| NORGES BANK |
13F
|
Company |
1.8%
|
1,043,854
|
$49,844,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.6%
|
952,736
|
$45,492,000 | — | 31 Dec 2019 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
900,000
|
$42,975,000 | — | 31 Dec 2019 | |
| Casdin Capital, LLC |
13F
|
Company |
1.4%
|
825,000
|
$39,394,000 | — | 31 Dec 2019 | |
| HealthCor Management, L.P. |
13F
|
Company |
1.2%
|
697,390
|
$33,300,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
682,871
|
$32,607,000 | — | 31 Dec 2019 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.1%
|
641,500
|
$30,632,000 | — | 31 Dec 2019 | |
| Artal Group S.A. |
13F
|
Company |
1%
|
600,000
|
$28,650,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.93%
|
550,945
|
$26,305,000 | — | 31 Dec 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.92%
|
548,353
|
$26,184,000 | — | 31 Dec 2019 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.83%
|
491,615
|
$23,474,000 | — | 31 Dec 2019 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.81%
|
479,882
|
$22,914,367 | — | 31 Dec 2019 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.78%
|
461,502
|
$22,037,000 | — | 31 Dec 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.59%
|
347,762
|
$16,606,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.58%
|
346,203
|
$16,531,000 | — | 31 Dec 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.56%
|
335,675
|
$16,029,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
320,839
|
$15,320,000 | — | 31 Dec 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.49%
|
289,426
|
$13,820,092 | — | 31 Dec 2019 | |
| AXA S.A. |
13F
|
Company |
0.47%
|
276,952
|
$13,225,000 | — | 31 Dec 2019 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.45%
|
268,733
|
$12,832,000 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.44%
|
262,389
|
$12,530,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.43%
|
255,633
|
$12,206,000 | — | 31 Dec 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.43%
|
254,674
|
$12,161,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.41%
|
244,373
|
$11,668,000 | — | 31 Dec 2019 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.4%
|
237,404
|
$11,336,000 | — | 31 Dec 2019 | |
| Maven Securities LTD |
13F
|
Company |
0.38%
|
225,000
|
$10,816,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.37%
|
217,410
|
$10,381,000 | — | 31 Dec 2019 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.36%
|
216,408
|
$10,333,000 | — | 31 Dec 2019 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.32%
|
190,000
|
$9,073,000 | — | 31 Dec 2019 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.29%
|
174,735
|
$8,344,000 | — | 31 Dec 2019 | |
| Elk Creek Partners, LLC |
13F
|
Company |
0.28%
|
166,922
|
$7,971,000 | — | 31 Dec 2019 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.27%
|
160,000
|
$7,640,000 | — | 31 Dec 2019 | |
| ZWJ INVESTMENT COUNSEL INC |
13F
|
Company |
0.26%
|
157,375
|
$7,515,000 | — | 31 Dec 2019 |
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) as of Q1 2020
As of 31 Mar 2020,
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) was held by
188 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,390,256 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Capital International Investors, Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, GOLDMAN SACHS GROUP INC, STATE STREET CORP, and ORBIMED ADVISORS LLC.
This page lists
188
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
192
Q1 2020 holders
188
Holder diff
-4
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.